Search
for
Sort by
Research 331–360 of 1000+
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Alopecia
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- LB1034 Meta-analysis of scalp transcriptome defines alopecia areata subtypes and molecular response to four (4) treatments with jak inhibiting properties
- Exploring the Gut Microbiome and Metabolome in Individuals with Alopecia Areata Disease
- Recent Advances in the Pathogenesis of Autoimmune Hair Loss Disease Alopecia Areata
- Alopecia areata after dupilumab for atopic dermatitis
- Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Systematic Review of Psychological Interventions for Quality of Life, Mental Health, and Hair Growth in Alopecia Areata and Scarring Alopecia
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction
- Platelet-rich plasma combined with intralesional triamcinolone acetonide for the treatment of alopecia areata: A case report
- Case of alemtuzumab-related alopecia areata management in MS
- Alopecia areata following COVID-19 vaccine: a systematic review
- A comparative study of therapeutic response to intralesional injections of platelet-rich plasma versus triamcinolone acetonide in alopecia areata
- MiR‐200c‐3p as a novel genetic marker and therapeutic tool for alopecia areata
- Exploring the efficacy of baricitinib in treating alopecia areata after failed Janus kinase inhibitor therapy
- Alteration in Hair Texture Following Regrowth in Alopecia Areata
- Delayed hypersensitivity reaction to intralesional triamcinolone acetonide following treatment for alopecia areata. Intradermal testing.
- Hearing threshold abnormalities in patients with alopecia areata
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- 51840 Efficacy of the Oral JAK1/JAK2 Inhibitor Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata: Pooled Results from the Multinational Double-Blind, Placebo-Controlled THRIVE-AA1 and THRIVE-AA2 Phase 3 Trials
- PLACK syndrome associated with alopecia areata and a novel homozygous base pair insertion in exon 18 of CAST gene
- Cyclosporine-Induced Alopecia in Childhood Nephrotic Syndrome – A Case Report
- Alopecia areata-like presentations with mogamulizumab therapy
- Alopecia areata treated with phenolisation and intravenous dexamethasone pulses
- Alopecia Areata Associated with Thymoma Presenting as a Diffuse Pleural Dissemination Mimicking Mesothelioma: Rare Concomitant Presentation
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Lichen planopilaris associated with hair extensions in a patient with alopecia areata: A case report